(Q27162929)
Statements
516.087±0 dalton
1 reference
UNII-46CWK97Z3K (English)
9 October 2016
C₂₀H₂₃BCl₂N₂O₉
1 reference
UNII-46CWK97Z3K (English)
18 November 2016
B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl
1 reference
UNII-46CWK97Z3K (English)
18 November 2016
B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)[C@H](CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl
1 reference
UNII-46CWK97Z3K (English)
18 November 2016
Identifiers
1 reference
UNII-46CWK97Z3K (English)
18 November 2016
2 references
UNII-46CWK97Z3K (English)
18 November 2016
2 references
ixazomib citrate (English)
18 November 2016
1 reference
Ixazomib citrate (English)
18 November 2016
1 reference
UNII-46CWK97Z3K (English)
18 November 2016
1 reference
IXAZOMIB CITRATE (English)
18 November 2016
813-102-2
1 reference
27 December 2018
1,3,2-Dioxaborolane-4,4-diacetic acid,2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo (English)
CAS no.: 1239908-20-3 (English)
1 reference
27 December 2018
1,3,2-Dioxaborolane-4,4-diacetic acid,2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo (English)
CAS no.: 1239908-20-3 (English)
1 reference
ixazomib citrate (English)
18 November 2016
1 reference
ixazomib citrate (English)
18 November 2016